Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

29. Dezember 2010 09:15 ET | Quelle: Lightlake Therapeutics, Inc

Lightlake Therapeutics, Inc Appoints Mary K Pendergast as Regulatory and Strategy Advisor

LONDON, Dec. 29, 2010 (GLOBE NEWSWIRE) -- Lightlake Therapeutics Inc (OTCBB:LLTP) is pleased to announce that it has appointed Mary K. Pendergast J.D., LL.M., as its advisor for Regulatory and...
16. Dezember 2010 10:33 ET | Quelle: Lightlake Therapeutics, Inc

Lightlake Therapeutics, Inc. Acquires a Patent With the Potential to Establish a New Treatment Paradigm to Terminate Addiction to Legal and Illegal Drugs

LONDON, Dec. 16, 2010 (GLOBE NEWSWIRE) -- Lightlake Therapeutics Inc (OTCBB:LLTP) has acquired US Patent 5,587,381, entitled: 'Method for terminating methadone maintenance through extinction of the...
29. November 2010 09:10 ET | Quelle: Lightlake Therapeutics, Inc

Lightlake Therapeutics, Inc. Secures Distinguished Executive as Chairman

LONDON, Nov. 29, 2010 (GLOBE NEWSWIRE) -- Lightlake Therapeutics, Inc. (OTCBB:LLTP), announces today that the company has secured seasoned healthcare executive Dr. Michael Sinclair to serve as its...